These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8121 related articles for article (PubMed ID: 11898358)

  • 1. [Prospects for developing treatment of uveal melanoma from the position of modern carcinogenesis concepts].
    Likhvantseva VG
    Vestn Oftalmol; 2002; 118(1):32-5. PubMed ID: 11898358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
    Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
    Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
    Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
    He YG; Mayhew E; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
    Krvavica A; Talan-Hranilović J; Belicza M
    Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
    Rashid AB; Grossniklaus HE
    Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas].
    Anurova OA; Likhvantseva VG; Vereshchagina MV
    Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14.
    Cai L; Li X; Zheng S; Wang Y; Wang Y; Li H; Yang J; Sun J
    Melanoma Res; 2009 Feb; 19(1):1-7. PubMed ID: 19430401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
    Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
    Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of bcl-2 antisense oligonucleotides on multidrug resistance of cultured uveal melanoma cells].
    Guo LJ; Wu ZY; Zhang S; Zheng JL; Zheng HL
    Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):73-6. PubMed ID: 12783683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological implications of stroma pattern formation in uveal melanoma.
    Clarijs R; Ruiter DJ; De Waal RM
    J Cell Physiol; 2003 Mar; 194(3):267-71. PubMed ID: 12548547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.
    Maloney SC; Marshall JC; Antecka E; Orellana ME; Fernandes BF; Martins C; Castiglione E; DI Cesare S; Logan P; Burnier MN
    Anticancer Res; 2009 Aug; 29(8):3059-64. PubMed ID: 19661316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
    Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
    Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclin-D1 in uveal malignant melanoma.
    Errico ME; Staibano S; Tranfa F; Bonavolonta G; Lo Muzio L; Somma P; Lucariello A; Mansueto G; D'Aponte A; Ferrara G; De Rosa G
    Anticancer Res; 2003; 23(3B):2701-6. PubMed ID: 12894561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.
    Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG
    Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 407.